Clínica Universidad de Navarra, Pamplona, Spain.
Clínica Universidad de Navarra, Pamplona, Spain; The Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
Adv Clin Chem. 2018;83:73-119. doi: 10.1016/bs.acc.2017.10.003. Epub 2017 Nov 23.
Liquid biopsy refers to the molecular analysis in biological fluids of nucleic acids, subcellular structures, especially exosomes, and, in the context of cancer, circulating tumor cells. In the last 10 years, there has been an intensive research in liquid biopsy to achieve a less invasive and more precise personalized medicine. Molecular assessment of these circulating biomarkers can complement or even surrogate tissue biopsy. Because of this research, liquid biopsy has been introduced in clinical practice, especially in oncology, prenatal screening, and transplantation. Here we review the biology, methodological approaches, and clinical applications of the main biomarkers involved in liquid biopsy.
液体活检是指对生物体液中的核酸、亚细胞结构,特别是外泌体,以及在癌症的情况下,循环肿瘤细胞进行的分子分析。在过去的 10 年中,人们对液体活检进行了深入研究,以实现更微创和更精确的个体化医疗。对这些循环生物标志物的分子评估可以补充甚至替代组织活检。由于这项研究,液体活检已被引入临床实践,特别是在肿瘤学、产前筛查和移植领域。在这里,我们综述了液体活检中涉及的主要生物标志物的生物学、方法学方法和临床应用。